Antipili antibody affords protection against experimental ascending pyelonephritis
about
Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tractAromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cellsProtection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptorsVirulence factors in Escherichia coli urinary tract infectionIn vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infectionEscherichia coli K1 RS218 interacts with human brain microvascular endothelial cells via type 1 fimbria bacteria in the fimbriated state.Ultraviolet irradiation disrupts somatic pili structure and functionMolecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis.The PapG tip adhesin of P fimbriae protects Escherichia coli from neutrophil bactericidal activityInhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells.Effects of ompA deletion on expression of type 1 fimbriae in Escherichia coli K1 strain RS218 and on the association of E. coli with human brain microvascular endothelial cells.Changing treatment patterns in urinary infectionsSerological response to Escherichia coli pili in pyelonephritis.Antigenic quantitation of type 1 fimbriae on the surface of Escherichia coli cells by an enzyme-linked immunosorbent inhibition assay.Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli.Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine.Loss of lectin-like activity in aberrant type 1 fimbriae of Escherichia coli.Enhancement of mannose-mediated stimulation of human granulocytes by type 1 fimbriae aggregated with antibodies on Escherichia coli surfaces.Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Modulation of Actinomyces viscosus colonization of mouse teeth in vivo by immunization with fimbrial adhesins.Change in degree of type 1 piliation of Escherichia coli during experimental peritonitis in the mouse.Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli.Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli.Population shift in mannose-specific fimbriated phase of Klebsiella pneumoniae during experimental urinary tract infection in mice.Role of Escherichia coli type 1 pilus in colonization of porcine ileum and its protective nature as a vaccine antigen in controlling colibacillosisLoss of pili and decreased attachment to human cells by Neisseria meningitidis and Neisseria gonorrhoeae exposed to subinhibitory concentrations of antibioticsUtilization of anion-exchange chromatography and monoclonal antibodies to characterize multiple pilus types on a uropathogenic Escherichia coli O6 isolateMechanism of interaction of Salmonella and Schistosoma species.Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infectionBacterial adherence in urinary tract infections caused by Escherichia coli.Bacterial lectins, cell-cell recognition and infectious disease.Dissociation and reassembly of Escherichia coli type 1 pili.Attenuation of antibody response to acute pyelonephritis by treatment with antibiotics.Oligomannoside-type glycopeptides inhibiting adhesion of Escherichia coli strains mediated by type 1 pili: preparation of potent inhibitors from plant glycoproteins.Laboratory and wild-type Klebsiella pneumoniae strains carrying mannose-inhibitable adhesins and receptors for coliphages T3 and T7 are more pathogenic for mice than are strains without such receptors.Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in miceBacterial attachment to uro-epithelial cells: mechanisms and consequences.Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells.Therapeutic efficacy of medicating drinking water with spectinomycin and lincomycin-spectinomycin in experimental Escherichia coli infection in poultry.
P2860
Q24631903-90A4F015-CEB2-44F5-BD4C-B81E28B3969CQ24644561-807A1CFA-3E53-499C-8497-FF2DC6F81CB6Q28360014-F6C6104D-401B-4603-AD59-E301390CFC72Q28468751-951DE95D-FC89-4682-8D21-B7635B3FAE8BQ33756496-10754EFC-A24A-4761-A0D0-038CCB4E61E2Q33768973-E83927CF-4C49-4673-921E-9138A48A7F22Q34092939-0AFE1C5C-7F2F-4A65-AF99-7819FB4FFA11Q34528446-5E2DBBBB-2AA0-48B5-B0CC-FF73AF567B7DQ34547122-6EB0B9D3-8E88-44B9-AF70-4825CEAC641CQ34674254-F2F02DC8-0D33-4FD2-9A7A-59416E5D0422Q35073815-94F313B7-06CC-413D-B09D-705CCD6FF85BQ35119835-5AE9C39D-434C-4D17-85B9-5F566D98E527Q36331724-9A7E25FB-B507-42CA-B419-CA3371F7270BQ36338087-FF585031-182D-4B45-802D-BCC802BEE648Q36348997-770F47A9-9756-4653-A404-5A47BE340C99Q36431487-68F25EA6-103E-4E5F-B3DC-874B18A8B841Q36443410-AAA5B382-A706-4BD7-B693-70BB43F3BBF4Q36588301-2C8C8C11-0CC5-415D-81EB-7AD670063350Q36951570-34430072-FF0A-459A-BD5F-1028A3E5AF78Q37013456-7AA604E2-F7F7-46A3-AEA1-2D5CC7205C54Q37013498-FC7CD120-1EE2-4C7C-A697-88703947E51FQ37013735-27CC884E-AF94-437C-8E21-8BCBFBF4CFDEQ37026131-7E126F21-BB05-4C83-BB7F-7EC89336F0B6Q37034253-98C891AD-605C-46C1-A051-022FE39E6AAFQ37035151-F080C5A6-8643-480F-BF7D-9333A977F6AEQ37041855-F4A4CF1F-7822-48A5-98BB-93EE0F2C07D4Q37056030-D2F64EAE-EB14-4601-8B80-BFB0B8B4892DQ37082165-F807E705-EB7E-40B7-85F8-8B79D7767D44Q37371765-BC1A2BB2-AF12-40E0-BCCA-FD21A4A51273Q39460107-F481AEC8-463A-499A-9D0D-3652B89A9542Q39463165-1D6FB475-BB36-4D3E-8F72-644029B182E3Q39971097-B4A018D0-D284-4913-9C25-2D935444AB26Q40088038-051DB596-8FC9-4D89-9EC6-6370987FAF3EQ40165763-6CCC59DF-8861-4672-B021-8CC09BE83389Q40599952-AC31BFA3-DD2A-48BF-8C3D-90C5E4F8107BQ40600501-B610FE9A-9D01-41C9-A21B-198F329445D0Q41730599-180995A2-95D7-48A1-AD87-DF6A1BA90D05Q54562224-BC5B515F-9F05-4341-B235-D5599ED89F09Q54746506-21C80C83-DB7E-404E-8CB9-8BE2F32FB793
P2860
Antipili antibody affords protection against experimental ascending pyelonephritis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1979
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antipili antibody affords protection against experimental ascending pyelonephritis
@en
Antipili antibody affords protection against experimental ascending pyelonephritis.
@nl
type
label
Antipili antibody affords protection against experimental ascending pyelonephritis
@en
Antipili antibody affords protection against experimental ascending pyelonephritis.
@nl
prefLabel
Antipili antibody affords protection against experimental ascending pyelonephritis
@en
Antipili antibody affords protection against experimental ascending pyelonephritis.
@nl
P2860
P356
P1476
Antipili antibody affords protection against experimental ascending pyelonephritis
@en
P2093
Silverblatt FJ
P2860
P304
P356
10.1172/JCI109458
P407
P577
1979-07-01T00:00:00Z